0.62 (-%)
As of Apr 12, 2024
Source:
Ampio Pharmaceuticals, Inc is a pre-revenue stage biopharmaceutical company that until February 2024 was focused on the development of a potential treatment for osteoarthritis of the knee (“OAK”) as part of its OA-201 development program.
| Country | United States |
| Headquarters | englewood, colorado |
| Phone Number | ( 720 ) 437-6500 |
| Industry | manufacturing |
| CEO | Michael A. Martino |
| Website | www.ampiopharma.com |